Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma
Status:
Active, not recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the addition of oral maintenance
chemotherapy with O-TIE (Etoposide, Idarubicin, Trofosfamide) for 6 months improves the event
free survival (EFS) in patients with localised high-risk RMS and RMS-like Soft Tissue
Sarcoma.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital Tuebingen
Collaborators:
Cooperative Weichteilsarkom Study Group Deutsche Kinderkrebsstiftung Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria Polish Paediatric Solid Tumours Study Group Swiss Pediatric Oncology Group The Swedish Childhood Solid Tumor Working Group